744 related articles for article (PubMed ID: 28548345)
1. EMT and MET: necessary or permissive for metastasis?
Jolly MK; Ware KE; Gilja S; Somarelli JA; Levine H
Mol Oncol; 2017 Jul; 11(7):755-769. PubMed ID: 28548345
[TBL] [Abstract][Full Text] [Related]
2. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
[TBL] [Abstract][Full Text] [Related]
3. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
Liao TT; Yang MH
Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
[TBL] [Abstract][Full Text] [Related]
4. Hybrid epithelial/mesenchymal phenotype(s): The 'fittest' for metastasis?
Jolly MK; Mani SA; Levine H
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):151-157. PubMed ID: 29997040
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation.
Yao D; Dai C; Peng S
Mol Cancer Res; 2011 Dec; 9(12):1608-20. PubMed ID: 21840933
[TBL] [Abstract][Full Text] [Related]
6. Distinct routes to metastasis: plasticity-dependent and plasticity-independent pathways.
Somarelli JA; Schaeffer D; Marengo MS; Bepler T; Rouse D; Ware KE; Hish AJ; Zhao Y; Buckley AF; Epstein JI; Armstrong AJ; Virshup DM; Garcia-Blanco MA
Oncogene; 2016 Aug; 35(33):4302-11. PubMed ID: 26751776
[TBL] [Abstract][Full Text] [Related]
7. EMT, MET, Plasticity, and Tumor Metastasis.
Bakir B; Chiarella AM; Pitarresi JR; Rustgi AK
Trends Cell Biol; 2020 Oct; 30(10):764-776. PubMed ID: 32800658
[TBL] [Abstract][Full Text] [Related]
8. EMT Transition States during Tumor Progression and Metastasis.
Pastushenko I; Blanpain C
Trends Cell Biol; 2019 Mar; 29(3):212-226. PubMed ID: 30594349
[TBL] [Abstract][Full Text] [Related]
9. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
Garg M
Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
[TBL] [Abstract][Full Text] [Related]
10. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe?
Diepenbruck M; Christofori G
Curr Opin Cell Biol; 2016 Dec; 43():7-13. PubMed ID: 27371787
[TBL] [Abstract][Full Text] [Related]
12. Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype.
Boareto M; Jolly MK; Goldman A; Pietilä M; Mani SA; Sengupta S; Ben-Jacob E; Levine H; Onuchic JN
J R Soc Interface; 2016 May; 13(118):. PubMed ID: 27170649
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.
Lu W; Kang Y
Dev Cell; 2019 May; 49(3):361-374. PubMed ID: 31063755
[TBL] [Abstract][Full Text] [Related]
14. Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step.
Chui MH
Int J Cancer; 2013 Apr; 132(7):1487-95. PubMed ID: 22833228
[TBL] [Abstract][Full Text] [Related]
15. Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation.
Aokage K; Ishii G; Ohtaki Y; Yamaguchi Y; Hishida T; Yoshida J; Nishimura M; Nagai K; Ochiai A
Int J Cancer; 2011 Apr; 128(7):1585-95. PubMed ID: 20533280
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal plasticity in carcinoma metastasis.
Tsai JH; Yang J
Genes Dev; 2013 Oct; 27(20):2192-206. PubMed ID: 24142872
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2.
Somarelli JA; Shetler S; Jolly MK; Wang X; Bartholf Dewitt S; Hish AJ; Gilja S; Eward WC; Ware KE; Levine H; Armstrong AJ; Garcia-Blanco MA
Mol Cell Biol; 2016 Oct; 36(19):2503-13. PubMed ID: 27402864
[TBL] [Abstract][Full Text] [Related]
18. To differentiate or not--routes towards metastasis.
Brabletz T
Nat Rev Cancer; 2012 May; 12(6):425-36. PubMed ID: 22576165
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer.
Gunasinghe NP; Wells A; Thompson EW; Hugo HJ
Cancer Metastasis Rev; 2012 Dec; 31(3-4):469-78. PubMed ID: 22729277
[TBL] [Abstract][Full Text] [Related]
20. EMT: Present and future in clinical oncology.
Santamaria PG; Moreno-Bueno G; Portillo F; Cano A
Mol Oncol; 2017 Jul; 11(7):718-738. PubMed ID: 28590039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
